Poor Asthma Control, Device Handling and Phenotype

Summary of Presentations Given at the Teva Symposium, ERS Annual Congress 2013, Barcelona, Spain

Chair: Roberto Rodiguez-Roisin1
J. Christian Virchow,2 Cynthia Rand,3 Richard Dekhuijzen,4 Michael Wechsler5

1. Senior Consultant Physician, Service of Respiratory Medicine, Hospital Clinic, Barcelona, Spain
2. Head, Department of Intervnal Medicine, Pulmonary Division, University of Rostock, Germany
3. Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Maryland, USA
4. Radboud University Medical Center, Nijmegen, the Netherlands
5. Professor of Medicine, Director of Asthma Programme, National Jewish Health, Colorado, USA

Disclosure: The speakers received honorarium from Teva for participating in this symposium.
Acknowledgements: Writing assistance provided by Trilogy Writing and Consulting Ltd.
Support: The publication of this article was funded by Teva and Teva received a Medical Accuracy review.
Citation: EMJ Respir. 2013;1:30-52.

Introduction

The aim of this symposium is to discuss the impact of poor treatment and poor inhaler technique on asthma outcomes. In addition, the symposium will explore the aetiology of asthma and the mechanistic role of IL-5 in severe asthma.

Download (PDF, 941KB)

Leave a Reply